In addition, individuals with pancreatic adenocarcinoma (PAAD), whose expression of the ‘‘eraser’’ gene ALKBH1 is low, have a worse prognosis in comparison to high expressers [24]. Here, ALKBH1 is linked to pancreatic adenocarcinoma.